‌

US Patent 7176211 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Patent 7176211 was granted and assigned to Neurocrine Biosciences on February, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Neurocrine Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Charles Q. Huang0

Dongpei Wu0

Fabio C. Tucci0

Warren Wade0

Wesley J. Dwight0

Yongsheng Chen0

Zhiqiang Guo0

Chen Chen0

Date of Patent

February 13, 2007

Patent Application Number

11251085

Date Filed

October 14, 2005

Patent Citations Received

US Patent 12102637 Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

0

US Patent 11918583 Treatment of heavy menstrual bleeding associated with uterine fibroids

0

US Patent 11957684 Treatment of heavy menstrual bleeding associated with uterine fibroids

0

US Patent 12083227 Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

0

Patent Primary Examiner

Patent abstract

GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7176211 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.